Contact TGA: | 1800 020 653 | More contact info Translate | Subscribe

TGA reforms

11 July 2012

The TGA mandate is to regulate medicines, medical devices and biological products throughout their lifecycle. The TGA is focusing on implementing changes to ensure a greater emphasis on transparency of regulatory decision-making processes, a continuing focus on business process reform and a more strategic approach to the use of information technology to support regulatory operations. These changes will ensure a smooth transition to the Australia New Zealand Therapeutic Products Agency.

Reforms underway as part of TGA Reforms: a blueprint for TGA's future include:

Content last updated: Wednesday, 11 July 2012

Content last reviewed: Wednesday, 11 July 2012

Web page last updated: Wednesday, 9 July 2014